ANRO
Alto Neuroscience, Inc.
NYSE: ANRO · HEALTHCARE · BIOTECHNOLOGY
$25.80
+6.15% today
Updated 2026-04-30
Market cap
$899.45M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.19
Dividend yield
—
52W range
$2 – $28
Volume
0.3M
WallStSmart proprietary scores
23
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C5.0
Quality
C+3.0
Profitability
D5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$35.27
+36.73%
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
0 Strong Buy9 Buy1 Hold0 Sell0 Strong Sell
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-11.52M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-27.71M | $-36.30M | $-61.43M | $-63.24M | $-16.18M |
| EPS | — | — | — | — | $-2.19 |
| Free cash flow | $-21.13M | $-33.92M | $-49.50M | $-51.79M | $-11.52M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
Alto Neuroscience, Inc. trades at $25.80. Our Smart Value Score of 23/100 indicates the stock is weak.
Frequently asked questions
What is Alto Neuroscience, Inc.'s stock price?
Alto Neuroscience, Inc. (ANRO) trades at $25.80.
Is Alto Neuroscience, Inc. overvalued?
Smart Value Score 23/100 (Grade F, Strong Sell).
What is the price target of Alto Neuroscience, Inc. (ANRO)?
The analyst target price is $35.27, representing +36.7% upside from the current price of $25.80.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNYSE
CurrencyUSD
Quick metrics
P/S ratio—
ROE-41.80%
Beta2.06
50D MA$22.39
200D MA$13.20
Shares out0.04B
Float0.02B
Short ratio—
Avg volume0.3M
Performance
1 week-4.82%
1 month+8.85%
3 months+59.73%
YTD+37.47%
1 year—
3 years—
5 years—